Susquehanna International Group
HCAT icon

Susquehanna International Group’s Health Catalyst HCAT Stock Holding History

Susquehanna International Group’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$45.8K Buy
+36,100
New +$67.9K ﹤0.01% 12658
2024
Q4 		– Sell
-11,600
Closed -$94.4K – 12609
2024
Q3 		$94.4K Buy
+11,600
New +$83.8K ﹤0.01% 11085
2022
Q4 		– Sell
-26,600
Closed -$258K – 12913
2022
Q3 		$258K Buy
26,600
+15,700
+144% +$208K ﹤0.01% 10189
2022
Q2 		$158K Buy
10,900
+3,200
+42% +$54.6K ﹤0.01% 10962
2022
Q1 		$201K Sell
7,700
-11,500
-60% -$326K ﹤0.01% 11225
2021
Q4 		$761K Sell
19,200
-64,600
-77% -$2.94M ﹤0.01% 8018
2021
Q3 		$4.19M Sell
83,800
-134,000
-62% -$7.31M ﹤0.01% 4262
2021
Q2 		$12.1M Buy
217,800
+138,900
+176% +$7.4M ﹤0.01% 2651
2021
Q1 		$3.69M Buy
78,900
+49,500
+168% +$2.4M ﹤0.01% 4513
2020
Q4 		$1.28M Sell
29,400
-23,400
-44% -$863K ﹤0.01% 6096
2020
Q3 		$1.93M Buy
52,800
+35,100
+198% +$1.19M ﹤0.01% 4688
2020
Q2 		$516K Buy
17,700
+7,200
+69% +$199K ﹤0.01% 7297
2020
Q1 		$275K Sell
10,500
-15,700
-60% -$480K ﹤0.01% 8144
2019
Q4 		$909K Buy
+26,200
New +$867K ﹤0.01% 5718

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Susquehanna International Group's HCAT Position: Q1 2026 in Review

Susquehanna International Group increased its Health Catalyst (HCAT) stake by 197% in Q1 2026, buying an estimated $101K and bringing the position to 81,154 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #12321.

Susquehanna International Group first reported a position in HCAT in Q1 2020 and has held it in 21 quarters since. The position peaked at $1.09M in Q3 2024. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Susquehanna International Group held 81,154 shares of Health Catalyst worth $103K as of Q1 2026.
  • Susquehanna International Group bought 53,830 Health Catalyst shares in Q1 2026, an estimated $101K.
  • Health Catalyst made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12321 holding.
  • Susquehanna International Group first reported a position in Health Catalyst in Q1 2020 and has held it in 21 quarters since.
  • Susquehanna International Group's Health Catalyst position peaked at $1.09M in Q3 2024.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.